Can Cyclosporine and Atorvastatin Be Given Together?
Yes, cyclosporine and atorvastatin can be co-administered, but only at low doses of atorvastatin (≤10 mg daily) with mandatory close monitoring for muscle toxicity. 1, 2, 3
Key Recommendation
The 2016 American Heart Association guidelines explicitly state that the combination of atorvastatin with cyclosporine may be considered, but with critical dose restrictions 1. This differs from simvastatin, lovastatin, and pitavastatin, which should be completely avoided with cyclosporine due to potentially harmful interactions 1.
Dosing Algorithm
Maximum atorvastatin dose with cyclosporine:
- ≤10 mg daily is the recommended maximum 1
- Doses >10 mg daily are not recommended without close monitoring of creatine kinase and signs/symptoms of muscle toxicity 1
The Pharmacologic Basis
The interaction is substantial and multifactorial:
Cyclosporine increases atorvastatin exposure by 6- to 15-fold through three mechanisms 1:
- Inhibition of hepatic OATP1B1 transporter (the primary mechanism) 4, 5
- Inhibition of CYP3A4 metabolism
- Inhibition of P-glycoprotein efflux
The FDA drug label confirms this interaction, noting that cyclosporine significantly increases atorvastatin plasma concentrations (AUC ratio: 8.69) 3. Both cyclosporine and atorvastatin have been associated with rhabdomyolysis when used together 1, 2.
Mandatory Monitoring Requirements
When co-administering these medications:
- Monitor creatine kinase levels regularly
- Assess for muscle pain, weakness, or tenderness at each visit
- Educate patients to report muscle symptoms immediately
- Consider baseline CK before starting therapy
- Monitor liver function tests (though recent data suggests this may be less concerning than previously thought) 6
Clinical Context and Nuances
Important distinction from tacrolimus: While the guidelines group cyclosporine and tacrolimus together, the actual clinical data shows cyclosporine has a 90-fold more potent inhibitory effect on OATP1B1 compared to tacrolimus 5. Recent evidence suggests high-intensity statins may be safer with tacrolimus than previously thought 6, but this does not apply to cyclosporine.
Real-world safety data: A 2023 Japanese study found low rates of statin intolerance (1.8%) in renal transplant recipients receiving cyclosporine with atorvastatin 7, suggesting that with appropriate dosing and monitoring, the combination can be managed safely in clinical practice.
Bidirectional interaction: While cyclosporine dramatically increases atorvastatin levels, atorvastatin does not significantly affect cyclosporine pharmacokinetics 8, 9. You do not need to adjust cyclosporine dosing when adding atorvastatin.
Alternative Statins to Consider
If higher-intensity lipid lowering is needed:
- Rosuvastatin (maximum 5 mg daily with cyclosporine) 1
- Pravastatin (maximum 20 mg daily with cyclosporine) 1
- Fluvastatin (maximum 40 mg daily with cyclosporine) 1
These alternatives have lower interaction potential but still require dose limitations.
Common Pitfalls to Avoid
- Do not use simvastatin, lovastatin, or pitavastatin with cyclosporine - these are contraindicated 1, 2
- Do not assume tacrolimus and cyclosporine have equivalent interactions - cyclosporine is far more potent as an OATP1B1 inhibitor 5
- Do not exceed 10 mg atorvastatin without compelling justification and intensive monitoring 1
- Do not forget that FDA labeling recommends avoiding atorvastatin with cyclosporine entirely 2, though clinical guidelines allow cautious use at low doses
Bottom Line for Practice
Start atorvastatin at 10 mg daily (or less) in patients on cyclosporine, monitor creatine kinase and muscle symptoms closely, and educate patients about the warning signs of myopathy. If inadequate lipid control is achieved, consider switching to an alternative statin with lower interaction potential rather than increasing atorvastatin dose. 1, 2